Navigation Links
eResearchTechnology, Inc. to Present at the UBS Global Healthcare Services Conference on February 10, 2009
Date:1/29/2009

PHILADELPHIA, Jan. 29 /PRNewswire-FirstCall/ -- eResearchTechnology, Inc. (ERT), (Nasdaq: ERES), a leading provider of centralized ECG and eClinical technology, ePRO, and other services to the pharmaceutical, biotechnology, medical device, and related industries, announced today that Dr. Michael J. McKelvey, the Company's President and Chief Executive Officer, is scheduled to present at the annual UBS Global Healthcare Services Conference at 2:00 p.m. EST on February 10, 2009 at the Waldorf-Astoria in New York City, New York.

Interested parties may access the presentation by visiting the Company's corporate website at www.ert.com. The webcast may also be accessed at http://cc.talkpoint.com/ubsx001/020909a_cy/?entity=40_0DTK1BE. The webcast will be available via replay for 90 days.

Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.ert.com) is a provider of technology and services to the pharmaceutical, biotechnology and medical device industries on a global basis. The company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements, including but not limited to 2008 financial guidance, involve a number of risks and uncertainties such as the company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the company's financial results can be found in the company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.


'/>"/>
SOURCE eResearchTechnology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. eResearchTechnology, Inc. to Present at the J.P. Morgan Healthcare Conference on January 13, 2009
2. eResearchTechnology, Inc. to Announce Agreement to Acquire the Centralized ECG Business of Covance
3. eResearchTechnology, Inc. to Announce 2007 Third Quarter Results on November 1, 2007
4. Triple-S Management Corporation to Present at UBS Global Healthcare Services Conference
5. International Medical Interpreter Association Appoints IMIA State Representatives
6. HealthSouth to Present at J.P. Morgan Healthcare Global High Yield & Leveraged Finance Conference
7. Hypertension & cholesterol medications present in water released into the St. Lawrence River
8. Rigel to Present at Keystone Symposia Conference
9. Infants draw on past to interpret present, understand other peoples behavior
10. Interleukin Genetics to Present Data Highlighting Link Between Inflammatory Gene Variations and Less Effective Weightloss
11. MEDai Presents on Transitioning Predictive Modeling Integration From Care Management to Actuarial Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... July 20, 2017 , ... ... enterprise-grade IT operations analytics and application performance monitoring (APM) solutions, has expanded ... healthcare services providers. , According to Peter Ohrenberger, sales director at Nastel, ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing homes, ... designed to accommodate patients with a wide range of ailments or special needs, but ... invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many uses, ...
(Date:7/20/2017)... , ... July 20, 2017 , ... Team Type 1 ... to medicine for everyone affected by diabetes, is teaming up with a Microsoft Corp. ... event kicks off on July 24th. , “Team Type 1’s mission overlaps seamlessly ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... development of non-invasive devices and systems for monitoring cardiopulmonary diseases, announced today that ... be used to complete regulatory submissions and fund final engineering and initial production ...
(Date:7/20/2017)... ... July 20, 2017 , ... Using CDRH’s Medical Device ... — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/mdqualitydata          , Device makers ... It’s known as the “CY2016 Annual FDA Medical Device Quality System Data” report. ...
Breaking Medicine News(10 mins):
(Date:7/1/2017)... WARSAW, Ind. , June 30, 2017 Zimmer ... second quarter sales and earnings conference call will be broadcast ... 8 a.m. Eastern Time.  A news release detailing the quarterly ... the morning of the conference call. The live ... website at http://investor.zimmerbiomet.com . It will be archived for ...
(Date:6/30/2017)... , June 29, 2017  Axium Pharmaceuticals Inc. is a pharmaceutical ... novel formulations and alternative dosage forms of existing biologically active ... ... on our waterless self-nano emulsifying formula, which is designed to ... We believe the spray will provide fast onset of action ...
(Date:6/20/2017)... LAGUNA HILLS, Calif. , June 20, 2017 /PRNewswire/ ... validate the use of MMprofiler with SKY92, the company,s ... (MM). In a poster presentation at the 22 nd ... Madrid, Spain , SkylineDx researchers will ... elderly patients. In a separate e-poster ...
Breaking Medicine Technology: